Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Heron Therapeutics, Inc. - Common Stock
(NQ:
HRTX
)
0.3660
-0.0183 (-4.76%)
Delayed Quote
Updated: 2:24 PM EDT, Oct 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Heron Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
These stocks are moving in today's after hours session
↗
September 30, 2026
Via
Chartmill
Get insights into the top gainers and losers of Tuesday's after-hours session.
↗
September 01, 2026
Via
Chartmill
Heron (HRTX) Q2 2026 Earnings Call Transcript
↗
August 17, 2026
Patent setback forces guidance withdrawal as acute care revenue surges 44% year over year.
Via
The Motley Fool
Topics
Earnings
Intellectual Property
Heron Therapeutics Q1 Results Miss, but Acute Care Growth and Reaffirmed Outlook Support HRTX
↗
May 11, 2026
Via
Chartmill
Heron Therapeutics Inc (NASDAQ:HRTX) Reports Q4 2025 Revenue Beat and Positive 2026 Outlook
↗
February 26, 2026
Via
Chartmill
Earnings Scheduled For November 4, 2025
↗
November 04, 2025
Via
Benzinga
Earnings Scheduled For May 6, 2025
↗
May 06, 2025
Via
Benzinga
Earnings Scheduled For February 27, 2025
↗
February 27, 2025
Via
Benzinga
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
Heron Therapeutics Q2 Earnings Call Highlights
↗
August 10, 2026
Heron Therapeutics (NASDAQ:HRTX) reported second-quarter net revenue of $37.7 million, up from $34.7 million in the first quarter and $37.2 million in the comparable prior-year period, while management...
Via
MarketBeat
Topics
Earnings
Intellectual Property
Keep an eye on the top gainers and losers in Tuesday's session.
↗
June 02, 2026
Via
Chartmill
These stocks are moving in today's session
↗
June 02, 2026
Via
Chartmill
Tuesday's session: gap up and gap down stocks
↗
June 02, 2026
Via
Chartmill
Which stocks are moving after the closing bell on Monday?
↗
June 01, 2026
Via
Chartmill
Heron (HRTX) Q1 2026 Earnings Call Transcript
↗
May 11, 2026
Heron (HRTX) Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Supply Chain
Which stocks are moving on Monday?
↗
May 11, 2026
Via
Chartmill
Heron Therapeutics Q1 Earnings Call Highlights
↗
May 11, 2026
Heron Therapeutics (NASDAQ:HRTX) said first-quarter 2026 results were pressured by seasonal factors and severe winter weather, but management reaffirmed its full-year outlook and pointed to improving...
Via
MarketBeat
Topics
Earnings
The market is filled with gapping stocks in Monday's session.
↗
May 11, 2026
Via
Chartmill
Heron (HRTX) Q4 2025 Earnings Call Transcript
↗
February 26, 2026
Heron (HRTX) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Heron Therapeutics Inc (NASDAQ:HRTX) Reports Mixed Q3 2025 Results, Misses Revenue and Earnings Estimates
↗
November 04, 2025
Heron Therapeutics reported mixed Q3 2025 results, missing revenue and earnings estimates. Despite strong growth from its Acute Care products, the miss led to a negative market reaction.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
↗
August 08, 2025
Via
Benzinga
These stocks are moving in today's session
↗
August 08, 2025
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
Traders are paying attention to the gapping stocks in Friday's session.
↗
August 08, 2025
Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
Heron (HRTX) Q2 Acute Care Jumps 56%
↗
August 08, 2025
Via
The Motley Fool
Topics
Economy
Intellectual Property
This Ryder System Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
June 09, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
December 04, 2024
Via
Benzinga
Why Marvell Technology Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
↗
December 04, 2024
Via
Benzinga
Starbucks To $77? Here Are 10 Top Analyst Forecasts For Wednesday
↗
November 13, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
November 12, 2024
Via
Benzinga
HRTX Stock Earnings: Heron Therapeutics Misses EPS, Beats Revenue for Q2 2024
↗
August 06, 2024
HRTX stock results show that Heron Therapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
